Archive · 21 Jul 2026
Anthem Biosciences Reports Q1 Profit Decline
Anthem Biosciences Limited recently shared its financial results for the first quarter of the fiscal year 2026-27.
The company made a net profit of ₹119.94 crore, but its revenue from operations went down by 31.54% compared to the previous quarter and by 22.58% compared to the same quarter last year.
The profit before tax was ₹144.58 crore, which is less than both the previous quarter and the same quarter last year.
The company's total expenses were ₹298.53 crore, which is lower than the previous quarters.
The CRDMO segment brought in ₹340.80 crore, while the Speciality Ingredients segment made ₹77.42 crore.
Employee benefit expenses increased to ₹78.84 crore.
The company's paid-up equity share capital as of 30 June 2026 was ₹112.68 crore.
Anthem Biosciences reported a net profit of ₹119.94 crore for Q1 FY 2026-27.
Revenue from operations declined by 31.54% compared to the previous quarter and 22.58% year-over-year.
Profit before tax was ₹144.58 crore, lower than the previous quarter and the same quarter last year.
Total expenses were ₹298.53 crore, a decrease from previous quarters.
The CRDMO segment contributed ₹340.80 crore, and the Speciality Ingredients segment generated ₹77.42 crore.
- Who
- Anthem Biosciences Limited
- What
- Reported Q1 financial results for FY 2026-27
- When
- Quarter ended 30 June 2026
- Where
- Mumbai
- Why
- To announce financial performance and operational updates
Financial Performance
Operational Challenges
Revenue Decline
Financial Performance
Revenue from operations decreased by 31.54% compared to the previous quarter and 22.58% year-over-year.
Operational Challenges
The company faced significant operational challenges leading to reduced revenue.
Profit Before Tax
Financial Performance
Profit before tax was ₹144.58 crore, lower than the previous quarter and the same quarter last year.
Operational Challenges
The decline in profit before tax indicates operational inefficiencies and higher expenses.
Employee Benefit Expenses
Financial Performance
Employee benefit expenses increased to ₹78.84 crore, up from the previous quarters.
Operational Challenges
The rise in employee benefit expenses reflects increased investment in human resources.
- Net Profit
- ₹119.94 crore
- Revenue from Operations
- ₹418.22 crore
- Profit Before Tax
- ₹144.58 crore
- Total Expenses
- ₹298.53 crore
- CRDMO Segment Revenue
- ₹340.80 crore
- Speciality Ingredients Segment Revenue
- ₹77.42 crore
- Employee Benefit Expenses
- ₹78.84 crore
- Paid-up Equity Share Capital
- ₹112.68 crore